NXC-201 (formerly HBI0101) Multiple Myeloma

Clinical trial NCT04720313 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04720313
Sponsor: Hadassah Medical Organization
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Dose Escalation and Safety

Start date: 2021-01-01
Primary completion: 2026-01-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.